Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose tacrolimus plus full-dose mycophenolic acid in marginal donor kidney transplantation
ChiCTR2000033156Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jul 2020
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus and mycophenolic acid in kidney failure (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Serum creatinine and Estimated glomerular filtration rate. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
tacrolimusmycophenolic acid
03
Conditions
kidney failure
Beyond the preview
Go deeper on ChiCTR2000033156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033156.